Stay updated on Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial

Sign up to get notified when there's something new on the Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with minimal HTML, replacing the former study record content and navigation. This means the NCT05980949 study details are no longer accessible from this URL.
    Difference
    21%
    Check dated 2026-09-26T00:37:47.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The UI text for finding contact information changed capitalization from 'Find Contact Information' to 'Find contact information'. The page revision updated from v3.6.6 to v3.7.0.
    Difference
    0.0%
    Check dated 2026-09-18T23:42:32.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The page now includes a 2023 U.S. NIH grant/contract funding note. It also updates the revision version to v3.6.6, from v3.6.5, indicating updated metadata and documentation.
    Difference
    0.0%
    Check dated 2026-08-28T20:57:57.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5, indicating a small metadata change to the page's revision history. This change does not alter the study details or content visible on the page.
    Difference
    0.0%
    Check dated 2026-08-07T10:23:45.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    The page metadata revision was updated from v3.6.3 to v3.6.4. This reflects a new release version of the page's documentation.
    Difference
    0.0%
    Check dated 2026-07-24T02:44:55.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    A new site in Vinnytsia, Ukraine (Site 8002) and the associated investigator were added, increasing the total number of locations to 429. The inclusion/eligibility language for KAR-033 was expanded to specify consent procedures, assent, and relocation considerations.
    Difference
    0.3%
    Check dated 2026-07-09T16:58:43.000Z thumbnail image

Stay in the know with updates to Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of KarXT in Alzheimer's Psychosis Clinical Trial page.